BDH Industries Ltd banner
B

BDH Industries Ltd
BSE:524828

Watchlist Manager
BDH Industries Ltd
BSE:524828
Watchlist
Price: 375.55 INR -2.44% Market Closed
Market Cap: ₹2.2B

BDH Industries Ltd
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

BDH Industries Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
B
BDH Industries Ltd
BSE:524828
Long-Term Debt
₹0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Debt
₹11.6B
CAGR 3-Years
86%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Debt
₹3B
CAGR 3-Years
24%
CAGR 5-Years
-34%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Debt
₹3.6B
CAGR 3-Years
-7%
CAGR 5-Years
-27%
CAGR 10-Years
-17%
Lupin Ltd
NSE:LUPIN
Long-Term Debt
₹18.4B
CAGR 3-Years
96%
CAGR 5-Years
146%
CAGR 10-Years
38%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Debt
₹12.4B
CAGR 3-Years
-20%
CAGR 5-Years
-19%
CAGR 10-Years
-6%
No Stocks Found

BDH Industries Ltd
Glance View

Market Cap
2.2B INR
Industry
Pharmaceuticals

BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. The company is headquartered in Mumbai, Maharashtra. The company is also involved in the manufacturing of therapeutic formulations. The company offers a range of oral solid dosages (OSD) technologies. The company offers its products in various therapeutic classes, such as antifungal, antibiotics, anticancer, anti-diabetic, antidepressant, anti-ulcerant, antimalarial, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, non-steroidal anti-inflammatory drugs, psychotropic, trichology, and vitamins and minerals. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, and Indomethacin Extended Release Capsules U.S.P. 75 mg.

BDH Intrinsic Value
249.88 INR
Overvaluation 33%
Intrinsic Value
Price ₹375.55
B

See Also

What is BDH Industries Ltd's Long-Term Debt?
Long-Term Debt
0 INR

Based on the financial report for Dec 31, 2025, BDH Industries Ltd's Long-Term Debt amounts to 0 INR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett